Evidence map›Paper›PMID 40357795›Full record

ArticleeLife2025

Dual-color optical activation and suppression of neurons with high temporal precision.

Noëmie Mermet-Joret, Andrea Moreno, Agnieszka Zbela, Milad Nazari, Bárður Eyjólfsson Ellendersen, Raquel Comaposada Baro, Nathalie Krauth, Anne von Philipsborn, Andreas Toft Sørensen, Joaquin Piriz and 2 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Strategies to Decipher Neuron Identity from Extracellular Recordings in Behaving Nonhuman Primates.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Practical considerations in an era of multicolor optogenetics.Frontiers in cellular neuroscience · 2023
    Article
  7. Red Light Optogenetics in Neuroscience.Frontiers in cellular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Noëmie Mermet-JoretDANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-9889-6647
Andrea MorenoDANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus, Denmark.
Agnieszka ZbelaTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Tasmania, Australia.ORCID https://orcid.org/0000-0002-7306-1168
Milad NazariDANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus, Denmark.
Bárður Eyjólfsson EllendersenDANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus, Denmark.
Raquel Comaposada BaroDepartment of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-8169-1218
Nathalie KrauthDANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-8048-7119
Anne von PhilipsbornDANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-7921-8744
Andreas Toft SørensenDepartment of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Joaquin PirizInstituto de Fisiología Biología Molecular y Neurociencias (IFIBYNE), Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-2738-445X
John Yu-Luen Lin *Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Tasmania, Australia.ORCID https://orcid.org/0000-0002-1723-4597
Sadegh Nabavi *DANDRITE, The Danish Research Institute of Translational Neuroscience, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-3940-1210

Funding

Structure guided design of photoselectable channelrhodopsinsR21EY027620 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEREZOV, VADIM, HIRES, SAMUEL ANDREW · 2016 to 2017
$451k
Australian Research Council FT160100056Danish National Research Foundation DNRF133Danish Research Institute of Translational Neuroscience 19958European Research Council 22736Lundbeck Foundation R273-2017-179Lundbeck Foundation R346-2020-1793Lundbeck Foundation R360-2021-650NEI NIH HHS R21 EY027620NEI NIH HHS R21EY027620
6 · The paper itself

Abstract

A well-known phenomenon in the optogenetic toolbox is that all light-gated ion channels, including red-shifted channelrhodopsins (ChRs), are activated by blue light, whereas blue-shifted ChRs are minimally responsive to longer wavelengths. Here, we took advantage of this feature to create a system which allows high-frequency activation of neurons with pulses of red light, while permitting the suppression of action potentials (APs) with millisecond precision by blue light. We achieved this by pairing an ultrafast red-shifted ChR with a blue light-sensitive anion channel of appropriately matching kinetics. This required screening several anion-selective ChRs, followed by a model-based mutagenesis strategy to optimize their kinetics and light spectra. Slice electrophysiology in the hippocampus as well as behavioral inspection of vibrissa movement demonstrate a minimal excitation from blue light. Of significant potential value, in contrast to existing tools, the system we introduce here allows high-frequency optogenetic excitation of neurons with red light, while blue light suppression of APs is confined within the duration of the light pulse.

Indexed as

Action PotentialsLightNeuronsOptogeneticsAnimalsChannelrhodopsinsColorHippocampusMiceChannelrhodopsinschannelrhodopsinD. melanogastermembrane channelsmousemutagenesisneuroscienceoptogeneticsrat

Identifiers

PMID40357795
PMCPMC12074635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.